Iannacone Matteo

  • Proof of concept (2026) — LiveRNA: Liver mRNA-based immunotherapies
  • Proof of concept (2023) — S-CAMS: Spirocyclic CAMs as novel and ultrapotent anti-HBV drugs (S-CAM)
  • Advanced (2023) — EUCLIDEAN: Acquired adaptive immune cell dysfunction and restoration in chronic hepatitis B
  • Proof of concept (2020) — 2LIVEr: IL-2 gene therapy for chronic hepatitis B virus infection
  • Consolidator (2016) — FATE: Functional Biology of Hepatic CD8+ T cells
  • Starting (2010) — IVM-VIRUS-nAb: In vivo dynamics of antibody responses to lymph-borne viruses

Lascia un commento